Cardiovascular disorders are diseases of the heart and blood vessels, including coronary artery disease, cerebrovascular disease, heart failure, and other circulatory conditions.
The image-guided therapy systems market is expected to grow from US$4.96 billion in 2024 to US$8.42 billion by 2033 at a 6.05% CAGR. Growth is tied to minimally invasive care, chronic disease demand, and advances in imaging, AI, and navigation systems.
The global advanced drug delivery systems market is projected to grow from $255 billion in 2024 to $439.7 billion by 2034 at a 5.6% CAGR. Cardiovascular disease applications dominate with 37.8% market share, while North America leads regionally with 41.3% of the market. Emerging technologies include 3D-printed drug implants, smart hydrogels, and magnetic nanofiber platforms.
India's pharmaceutical industry, valued at Rs. 5.41 lakh crore in 2025, is transitioning from a generics powerhouse to an innovation-driven sector focused on biosimilars, complex formulations, and global R&D capabilities.
The global precision medicine market reached $98.87 billion in 2024 and is projected to grow at 14.8% CAGR through 2033, driven by genomic sequencing advances, chronic disease prevalence, and AI-driven diagnostics adoption.
Drug discovery outsourcing, preparative chromatography, and Latin America point-of-care diagnostics markets are forecast to grow at CAGRs between 7.5% and 8.2% through 2031, driven by biologics expansion and chronic disease prevalence.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04684602 |
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions |
RECRUITING | PHASE1/PHASE2 |
| NCT02419898 |
Oxfordshire Women and Their Children's Health |
UNKNOWN | |
| NCT01770210 |
Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events |
COMPLETED | |
| NCT01524276 |
Product Surveillance Registry |
RECRUITING |
